LEXICON PHARMACEUTICALS, INC. Chart calendar Lexicon Pharmaceuticals, Inc.
e9a985245cd860bd225e7b90479b1d1.nrEE7A8f5lzR5wB40jmWtXtv4No-8zYuoREMmhTwSKg.5vBAn2VviAiehkxJ63va2BkE0q5ZxHRm6lRGzSGfIc3K2DeGN0iRL6mLRQ~774e78e622e71a4872d43358fa3aea5e
Upcoming events on Lexicon Pharmaceuticals, Inc.
Past events on Lexicon Pharmaceuticals, Inc.
| 2024-04-22 09:00 am | Investor Day |
| 2024-04-15 | Piper Sandler Spring Biopharma Symposium |
| 2024-04-10 01:30 pm | Needham Healthcare Conference |
| 2024-04-09 | Piper Sandler Virtual Cardiovascular Day |
| 2024-04-08 12:25 pm | American College of Cardiology Scientific Meeting - Sotagliflozin Reduces Stroke |
| 2024-04-08 12:15 pm | American College of Cardiology Scientific Meeting - Rahul Aggarwal |
| 2024-04-07 | Needham Healthcare Conference |
| 2024-04-07 01:15 pm | American College of Cardiology Scientific Meeting - Preston Mason |
| 2024-04-07 01:15 pm | American College of Cardiology Scientific Meeting - Sotagliflozin, a Dual SGLT 1 and 2 Inhibitor |
| 2024-04-07 11:30 am | American College of Cardiology Scientific Meeting - Livia Stanger |
| 2024-04-07 11:30 am | American College of Cardiology Scientific Meeting - Sotagliflozin, a First-in-Class SGLT1/2 Inhibito |
| 2024-04-07 10:00 am | American College of Cardiology Scientific Meeting - Temporal Shift in Heart Failure Medications |
| 2024-04-07 09:15 am | American College of Cardiology Scientific Meeting - Mario Enrico Canonico |
| 2024-03-12 03:40 pm | Leerink Partners Global Biopharma Conference |
| 2024-03-11 07:15 am | Q4 2023 Earnings Release |
| 2024-01-11 01:30 pm | JPMorgan Healthcare Conference |
| 2023-11-30 09:30 am | Piper Sandler Healthcare Conference |
| 2023-11-28 02:35 pm | Evercore ISI HealthCONx Conference |
| 2023-11-15 12:00 pm | Jefferies London Healthcare Conference |
| 2023-11-12 03:30 pm | American Heart Association Scientific Meeting - Preston Mason |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 322 323 -0.44% | 24,0 77,0 -68.86% | 0,30 0,29 3% | 0,14 0,14 -1.19% | 1,20 1,74 -30.94% | 25,8 |
|
EBITDA Million USD | Released Forecast Spread | 174 112 55.18% | -44,9 -134 66.46% | -86,8 -88,0 1.39% | -100 -94,2 -6.54% | -171 -178 3.7% | -168 |
|
EBIT Million USD | Released Forecast Spread | 141 110 28.06% | -47,8 -71,9 33.54% | -87,1 -88,8 1.88% | -101 -95,0 -6.06% | -172 -178 3.33% | -201 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 124 86,6 43.37% | -58,6 -137 57.12% | -87,8 -89,2 1.61% | -102 -96,3 -5.91% | -176 -181 2.9% | -199 |
|
Net income Million USD | Released Forecast Spread | 130 96,1 35.36% | -58,6 -123 52.52% | -87,8 -89,2 1.61% | -102 -96,3 -5.91% | -176 -181 2.9% | -199 |
|
EPS USD | Released Forecast Spread | 1,16 0,84 37.65% | -0,53 -1,10 51.62% | -0,60 -0,61 0.91% | -0,62 -0,56 -10.11% | -0,79 -0,80 0.78% | -0,71 |
| Announcement Date | 12/03/20 | 10/03/21 | 28/02/22 | 02/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,01 0,00 - | 0,04 0,05 -26% | 0,04 0,10 -65% | 0,04 0,05 -22% | 0,03 0,05 -44% | 0,02 0,03 -27.99% | 0,32 0,13 137.76% | 0,16 2,06 -92.14% | 0,70 1,24 -43.47% | 1,37 | 2,97 | 9,39 | 12,1 | 21,0 |
|
EBITDA Million USD | Released Forecast Spread | -25,2 -25,0 -0.87% | -23,3 -24,0 3.04% | -46,6 -53,2 12.38% | -50,7 | -46,0 | -39,6 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -25,3 -26,5 4.42% | -23,4 -23,7 1.35% | -24,0 -23,9 -0.45% | -23,1 -23,0 -0.57% | -30,3 -24,7 -22.42% | -31,1 -31,3 0.48% | -44,2 -34,9 -26.83% | -49,6 -47,8 -3.9% | -46,7 -52,6 11.16% | -50,9 | -50,6 | -46,6 | -48,6 | -41,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,6 -26,6 3.54% | -23,5 -23,7 0.95% | -24,6 -23,9 -2.87% | -23,4 -23,0 -1.84% | -30,5 -24,7 -23.29% | -31,9 -31,6 -1.19% | -44,9 -35,2 -27.52% | -50,5 -48,0 -5.33% | -48,2 -53,5 9.74% | -51,7 | -50,7 | -46,4 | -48,2 | -41,2 |
|
Net income Million USD | Released Forecast Spread | -25,6 -26,6 3.54% | -23,5 -23,7 0.95% | -24,6 -23,9 -2.87% | -23,4 -23,0 -1.84% | -30,5 -24,7 -23.29% | -31,9 -31,6 -1.19% | -44,9 -35,2 -27.52% | -50,5 -48,0 -5.33% | -48,2 -53,5 9.74% | -51,7 | -50,7 | -46,4 | -48,2 | -41,2 |
|
EPS USD | Released Forecast Spread | -0,17 -0,18 7.04% | -0,16 -0,17 3.43% | -0,16 -0,16 0.69% | -0,13 -0,14 7.2% | -0,16 -0,13 -19.53% | -0,17 -0,18 5.21% | -0,22 -0,17 -25.97% | -0,21 -0,21 2.17% | -0,20 -0,22 7.91% | -0,20 | -0,18 | -0,17 | -0,16 | -0,16 |
| Announcement Date | 28/02/22 | 05/05/22 | 02/08/22 | 09/11/22 | 02/03/23 | 02/05/23 | 03/08/23 | 08/11/23 | 11/03/24 | - | - | - | - | - |
More events
